174 related articles for article (PubMed ID: 29722001)
1. Cystatin C takes part in melanoma-microglia cross-talk: possible implications for brain metastasis.
Moshe A; Izraely S; Sagi-Assif O; Prakash R; Telerman A; Meshel T; Carmichael T; Witz IP
Clin Exp Metastasis; 2018 Aug; 35(5-6):369-378. PubMed ID: 29722001
[TBL] [Abstract][Full Text] [Related]
2. The metastatic microenvironment: Melanoma-microglia cross-talk promotes the malignant phenotype of melanoma cells.
Izraely S; Ben-Menachem S; Sagi-Assif O; Telerman A; Zubrilov I; Ashkenazi O; Meshel T; Maman S; Orozco JIJ; Salomon MP; Marzese DM; Pasmanik-Chor M; Pikarski E; Ehrlich M; Hoon DSB; Witz IP
Int J Cancer; 2019 Feb; 144(4):802-817. PubMed ID: 29992556
[TBL] [Abstract][Full Text] [Related]
3. Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene.
Huh CG; Håkansson K; Nathanson CM; Thorgeirsson UP; Jonsson N; Grubb A; Abrahamson M; Karlsson S
Mol Pathol; 1999 Dec; 52(6):332-40. PubMed ID: 10748866
[TBL] [Abstract][Full Text] [Related]
4. The metastatic microenvironment: Brain-derived soluble factors alter the malignant phenotype of cutaneous and brain-metastasizing melanoma cells.
Klein A; Sagi-Assif O; Izraely S; Meshel T; Pasmanik-Chor M; Nahmias C; Couraud PO; Erez N; Hoon DS; Witz IP
Int J Cancer; 2012 Dec; 131(11):2509-18. PubMed ID: 22447293
[TBL] [Abstract][Full Text] [Related]
5. The melanoma brain metastatic microenvironment: aldolase C partakes in shaping the malignant phenotype of melanoma cells - a case of inter-tumor heterogeneity.
Izraely S; Ben-Menachem S; Sagi-Assif O; Meshel T; Malka S; Telerman A; Bustos MA; Ramos RI; Pasmanik-Chor M; Hoon DSB; Witz IP
Mol Oncol; 2021 May; 15(5):1376-1390. PubMed ID: 33274599
[TBL] [Abstract][Full Text] [Related]
6. Cystatin E/M suppresses legumain activity and invasion of human melanoma.
Briggs JJ; Haugen MH; Johansen HT; Riker AI; Abrahamson M; Fodstad Ø; Maelandsmo GM; Solberg R
BMC Cancer; 2010 Jan; 10():17. PubMed ID: 20074384
[TBL] [Abstract][Full Text] [Related]
7. Long-term characterization of activated microglia/macrophages facilitating the development of experimental brain metastasis through intravital microscopic imaging.
Qiao S; Qian Y; Xu G; Luo Q; Zhang Z
J Neuroinflammation; 2019 Jan; 16(1):4. PubMed ID: 30616691
[TBL] [Abstract][Full Text] [Related]
8. Cystatin C Shifts APP Processing from Amyloid-β Production towards Non-Amyloidgenic Pathway in Brain Endothelial Cells.
Wang XF; Liu DX; Liang Y; Xing LL; Zhao WH; Qin XX; Shang DS; Li B; Fang WG; Cao L; Zhao WD; Chen YH
PLoS One; 2016; 11(8):e0161093. PubMed ID: 27532339
[TBL] [Abstract][Full Text] [Related]
9. Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells.
Zubrilov I; Sagi-Assif O; Izraely S; Meshel T; Ben-Menahem S; Ginat R; Pasmanik-Chor M; Nahmias C; Couraud PO; Hoon DS; Witz IP
Cancer Lett; 2015 May; 361(1):86-96. PubMed ID: 25725450
[TBL] [Abstract][Full Text] [Related]
10. RNA Sequencing Analysis Reveals Interactions between Breast Cancer or Melanoma Cells and the Tissue Microenvironment during Brain Metastasis.
Sato R; Nakano T; Hosonaga M; Sampetrean O; Harigai R; Sasaki T; Koya I; Okano H; Kudoh J; Saya H; Arima Y
Biomed Res Int; 2017; 2017():8032910. PubMed ID: 28210624
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of motility and invasion of B16 melanoma by the overexpression of cystatin C.
Sexton PS; Cox JL
Melanoma Res; 1997 Apr; 7(2):97-101. PubMed ID: 9167174
[TBL] [Abstract][Full Text] [Related]
12. Cystatin C induces apoptosis and tyrosine hydroxylase gene expression through JNK-dependent pathway in neuronal cells.
Liang X; Nagai A; Terashima M; Sheikh AM; Shiota Y; Mitaki S; Kim SU; Yamaguchi S
Neurosci Lett; 2011 Jun; 496(2):100-5. PubMed ID: 21504781
[TBL] [Abstract][Full Text] [Related]
13. Recombinant adenovirus snake venom cystatin inhibits the growth, invasion, and metastasis of B16F10 cells in vitro and in vivo.
Xie Q; Tang N; Lin Y; Wang X; Lin X; Lin J
Melanoma Res; 2013 Dec; 23(6):444-51. PubMed ID: 24128788
[TBL] [Abstract][Full Text] [Related]
14. Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis.
Das SK; Guo C; Pradhan AK; Bhoopathi P; Talukdar S; Shen XN; Emdad L; Subler MA; Windle JJ; Sarkar D; Wang XY; Fisher PB
Oncotarget; 2016 Jul; 7(30):46848-46861. PubMed ID: 27341128
[TBL] [Abstract][Full Text] [Related]
15. CCR4 is a determinant of melanoma brain metastasis.
Klein A; Sagi-Assif O; Meshel T; Telerman A; Izraely S; Ben-Menachem S; Bayry J; Marzese DM; Ohe S; Hoon DSB; Erez N; Witz IP
Oncotarget; 2017 May; 8(19):31079-31091. PubMed ID: 28415693
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic TLR9 stimulation reduces brain metastasis through microglia activation.
Benbenishty A; Gadrich M; Cottarelli A; Lubart A; Kain D; Amer M; Shaashua L; Glasner A; Erez N; Agalliu D; Mayo L; Ben-Eliyahu S; Blinder P
PLoS Biol; 2019 Mar; 17(3):e2006859. PubMed ID: 30921319
[TBL] [Abstract][Full Text] [Related]
17. Epigenomic landscape of melanoma progression to brain metastasis: unexplored therapeutic alternatives.
Marzese DM; Witz IP; Kelly DF; Hoon DS
Epigenomics; 2015; 7(8):1303-11. PubMed ID: 26638944
[TBL] [Abstract][Full Text] [Related]
18. Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model.
Mercurio L; Ajmone-Cat MA; Cecchetti S; Ricci A; Bozzuto G; Molinari A; Manni I; Pollo B; Scala S; Carpinelli G; Minghetti L
J Exp Clin Cancer Res; 2016 Mar; 35():55. PubMed ID: 27015814
[TBL] [Abstract][Full Text] [Related]
19. Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice.
Bengtsson E; To F; Håkansson K; Grubb A; Brånén L; Nilsson J; Jovinge S
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2151-6. PubMed ID: 16051881
[TBL] [Abstract][Full Text] [Related]
20. Ectopic expression of MCAM/MUC18 increases in vitro motility and invasiveness, but decreases in vivo tumorigenesis and metastasis of a mouse melanoma K1735-9 subline in a syngeneic mouse model.
Wu GJ
Clin Exp Metastasis; 2016 Dec; 33(8):817-828. PubMed ID: 27510563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
